Brotizolam increased glucose delta area under curve response to the OGTT by 122 % ( p < 0.01 ) and zolpidem by 86 % ( p < 0.01 ) without significant variations of insulin levels , suggesting an impact on insulin sensitivity and/or insulin secretion .